By Ronald Boumans, Emergo Group
Last week there were already some rumors about Instituto Italiano del Marchio di Qualita S.P.A. (IMQ) being designated for the Medical Devices Regulation (EU) 2017/745 (MDR). Now this designation has been published in Nando. IMQ is the fourth Notified Body (NB) to be designated, after BSI Assurance UK Ltd, TÜV SÜD Product Service GmbH and DEKRA Certification GmbH. Given Brexit-related uncertainties in the UK and their potential impact for BSI, IMQ is, for now, the third EU-based option for companies who want to certify under the MDR.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.